A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma

Mise à jour : Il y a 5 ans
Référence : NCT00426764

Femme et Homme

Extrait

The purpose of this study is to evaluate the activity of romidepsin in patients with progressive or relapsed peripheral T-cell lymphoma (PTCL) who have already been treated with systemic therapy.


Critère d'inclusion

  • Peripheral T-Cell Lymphoma


Liens